Estech developed a range of cutting-edge cardiac surgery tools addressing three high growth areas in cardiac surgery:

A full RF ablation platform for minimally invasive procedures, a range of surgical instruments for least invasive valve (LIV) procedures and a suite of products for CABG procedures.

Stage Capital invested in Estech in 2009 and merged the company with NASDAQ listed Atricure in December 2013.

Headquarters
USA

INVESTMENT DATE
June 2009

INVESTMENT THESIS
Venture-stage investment in medical technology

STATUS
Realised

INDUSTRY
Cardiovascular

STAGE CAPITAL TEAM
Aris Constantinides